ETH
EBACW

Exos TFP Holdings’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Exos TFP Holdings’s Portfolio EBACW Stock Details EBACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,094
Closed -$326 – 570
2022
Q4 		$326 Buy
1,094
+244
+29% +$49 ﹤0.01% 517
2022
Q3 		$0 Buy
+850
New +$93 ﹤0.01% 497

Exos TFP Holdings's EBACW Position: Q1 2023 in Review

Exos TFP Holdings sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 1,094 shares — an estimated $326 sold.

Exos TFP Holdings first reported a position in EBACW in Q3 2022 and held it in 2 quarters. The position peaked at $326 in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • Exos TFP Holdings reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 1,094 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $326.
  • Exos TFP Holdings first reported a position in European Biotech Acquisition Corp. Warrant in Q3 2022 and held it in 2 quarters.
  • Exos TFP Holdings's European Biotech Acquisition Corp. Warrant position peaked at $326 in Q4 2022.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Exos TFP Holdings's 13F filing for Q1 2023, filed 10 May 2023.